N-cadherin is upregulated while E-cadherin is downregulated during EMT in cancers and this “cadherin switch” is associated with enhanced migratory and invasive traits, which caused inferior patient survival rate [47,65,66]. The gene discussed is CDH1; the disease is cancer.